The researchers found that the new method could pick up early signs of the cancer in people who had tested negative based on traditional alpha-fetoprotein (AFP) and ultrasound examinations.
A Chinese genomics firm says it has found a way to detect liver cancer linked to hepatitis B months before it can be picked up by other methods.
The conclusion was based on a study by Genetron Health and the Chinese Academy of Medical Sciences Cancer Hospital using a method called HCCscreen, which applies artificial intelligence to look for tumour-related mutations in DNA in blood.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
